Michael J. Puzo’s AbbVie ABBV Stock Holding History

Michael J. Puzo’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.05M	Hold	9,422	–	–	0.6%	36
2025 Q4	$2.15M	Hold	9,422	–	–	0.59%	35
2025 Q3	$2.18M	Sell	9,422 -25	-0.3%	-$5.09K	0.6%	37
2025 Q2	$1.75M	Sell	9,447 -540	-5%	-$100K	0.5%	37
2025 Q1	$2.09M	Sell	9,987 -250	-2%	-$48.6K	0.6%	35
2024 Q4	$1.82M	Sell	10,237 -410	-4%	-$75.4K	0.51%	35
2024 Q3	$2.1M	Sell	10,647 -117	-1%	-$21.8K	0.55%	37
2024 Q2	$1.85M	Sell	10,764 -305	-3%	-$50.5K	0.51%	37
2024 Q1	$2.02M	Sell	11,069 -55	-0.5%	-$9.48K	0.56%	36
2023 Q4	$1.72M	Hold	11,124	–	–	0.55%	37
2023 Q3	$1.66M	Sell	11,124 -685	-6%	-$101K	0.56%	37
2023 Q2	$1.59M	Sell	11,809 -453	-4%	-$66.4K	0.5%	40
2023 Q1	$1.95M	Sell	12,262 -136	-1%	-$20.8K	0.65%	38
2022 Q4	$2M	Sell	12,398 -50	-0.4%	-$7.67K	0.72%	34
2022 Q3	$1.67M	Sell	12,448 -260	-2%	-$37.3K	0.63%	39
2022 Q2	$1.95M	Sell	12,708 -460	-3%	-$70.3K	0.69%	41
2022 Q1	$2.13M	Sell	13,168 -935	-7%	-$136K	0.64%	40
2021 Q4	$1.91M	Buy	14,103 +1,143	+9%	+$135K	0.54%	40
2021 Q3	$1.4M	Sell	12,960 -215	-2%	-$24.6K	0.44%	44
2021 Q2	$1.48M	Sell	13,175 -3,000	-19%	-$338K	0.46%	44
2021 Q1	$1.75M	Buy	16,175 +225	+1%	+$24.1K	0.56%	43
2020 Q4	$1.71M	Sell	15,950 -50	-0.3%	-$4.8K	0.56%	41
2020 Q3	$1.4M	Hold	16,000	–	–	0.5%	43
2020 Q2	$1.57M	Hold	16,000	–	–	0.59%	40
2020 Q1	$1.22M	Hold	16,000	–	–	0.54%	40
2019 Q4	$1.42M	Sell	16,000 -576	-3%	-$47.8K	0.51%	42
2019 Q3	$1.25M	Hold	16,576	–	–	0.47%	42
2019 Q2	$1.21M	Sell	16,576 -250	-1%	-$19.6K	0.45%	44
2019 Q1	$1.36M	Sell	16,826 -200	-1%	-$16.4K	0.53%	41
2018 Q4	$1.57M	Sell	17,026 -150	-0.9%	-$13.2K	0.7%	37
2018 Q3	$1.63M	Sell	17,176 -500	-3%	-$47.4K	0.61%	39
2018 Q2	$1.64M	Sell	17,676 -900	-5%	-$87.9K	0.69%	36
2018 Q1	$1.76M	Sell	18,576 -550	-3%	-$60.4K	0.75%	35
2017 Q4	$1.85M	Buy	19,126 +1,900	+11%	+$179K	0.76%	34
2017 Q3	$1.53M	Sell	17,226 -100	-0.6%	-$7.61K	0.8%	38
2017 Q2	$1.26M	Hold	17,326	–	–	0.68%	39
2017 Q1	$1.13M	Hold	17,326	–	–	0.63%	42
2016 Q4	$1.08M	Hold	17,326	–	–	0.63%	42
2016 Q3	$1.09M	Hold	17,326	–	–	0.63%	43
2016 Q2	$1.07M	Sell	17,326 -25	-0.1%	-$1.52K	0.71%	41
2016 Q1	$992K	Buy	17,351 +3,400	+24%	+$190K	0.66%	43
2015 Q4	$825K	Buy	13,951 +904	+7%	+$52.1K	0.58%	46
2015 Q3	$709K	Buy	13,047 +305	+2%	+$19.9K	0.5%	51
2015 Q2	$856K	Buy	12,742 +281	+2%	+$18.3K	0.55%	49
2015 Q1	$730K	Hold	12,461	–	–	0.47%	55
2014 Q4	$814K	Buy	12,461 +160	+1%	+$10.1K	0.53%	52
2014 Q3	$711K	Hold	12,301	–	–	0.49%	51
2014 Q2	$694K	Hold	12,301	–	–	0.48%	52
2014 Q1	$632K	Hold	12,301	–	–	0.45%	56
2013 Q4	$650K	Hold	12,301	–	–	0.47%	54
2013 Q3	$551K	Hold	12,301	–	–	0.46%	53
2013 Q2	$507K	Buy	+12,301	New	+$538K	0.45%	55

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Michael J. Puzo's ABBV Position: Q1 2026 in Review

Michael J. Puzo held its AbbVie (ABBV) position steady in Q1 2026 at 9,422 shares worth $2.05M. The position accounts for 0.6% of the portfolio, ranked #36.

Michael J. Puzo first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.18M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Michael J. Puzo held 9,422 shares of AbbVie worth $2.05M as of Q1 2026.
Michael J. Puzo left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.6% of Michael J. Puzo's portfolio in Q1 2026, its #36 holding.
Michael J. Puzo first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Michael J. Puzo's AbbVie position peaked at $2.18M in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Michael J. Puzo's 13F filing for Q1 2026, filed 7 May 2026.